Market Research Blog

It is expected that by 2033, the Veterinary Vaccines Market will have increased from US$ 11.3 billion to US$ 20.82 billion. Between 2023 and 2033, this is anticipated to significantly increase the market share of veterinary vaccines and achieve a CAGR of 6.2%.

The global veterinary vaccines market is anticipated to showcase a robust CAGR of around 7.2% CAGR between 2022 and 2026. The global market was expected to register a year-on-year (YoY) growth rate of 6.5% and the global veterinary vaccines market size was valued at around US$ 10 Bn in 2021. The market is predicted to register a valuation surpassing around US$ 14.1 Bn by 2026.

The growth of the global veterinary vaccines market is expected to surge amid the increasing prevalence of animal diseases all over the world. Sales of veterinary vaccines accounted for around 91.3% share of the global veterinary biologics market in 2021. Based on product, the attenuated live vaccines segment leads the veterinary vaccines market with nearly ¼ market share.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-409

As the threat of another pandemic bestows over the world, improving animal health is one of the major priorities for people and governments all over the world. On an annual basis, billions of dollars are being spent on pharmaceuticals and vaccines to protect animals from a wide range of diseases as well as to improve their immunity. This is expected to generate growth prospects for veterinary vaccine suppliers and manufacturers during the forecast period. Surging efforts to develop vaccines for zoonotic diseases which are also commonly found in humans as well is set to improve the growth of the overall veterinary vaccines market.

Veterinary vaccines have rapidly become ideal preventive healthcare solutions in order to protect animals from developing and contracting lethal diseases as well as for improving their immunity systems. These vaccines allow pet owners and farmers to significantly reduce the spread of infectious diseases, improve their pet’s health and minimize healthcare costs. The variation between the BPS values observed within the global veterinary vaccines market in H1, 2022 – outlook over the H1, 2022 projected period reflects a decline of 20 BPS units. Furthermore, a decline in BPS growth in H1-2022 over H1-2021 by 13 Basis Point Share (BPS) is demonstrated by the market.

Key Takeaways

• The global veterinary vaccines market is gaining traction over the projection period due to the rising prevalence of zoonotic diseases, surging demand for animal products, and growing trend of pet adoption across the world. Among some of the key driving factors of the global veterinary vaccines market is the exponential growth of the animal healthcare products market.
• The rapid expansion of the veterinary respiratory disease treatment market along with the veterinary pain management drugs market attributed to the increasing spending by pet owners on improving the health of their pets will create sales prospects for veterinary vaccines throughout the forecast period.
• Massive popularity can be seen within the veterinary vaccines market for their potential to protect animal health along with public health as they effectively mimic naturally acquired immunity. Among the developing nations, veterinary vaccine sales are estimated to be high owing to the increasing pet ownership. These vaccines play a crucial role in assuring longevity and good health in animals.
• The introduction of technologically advanced vaccinations, increasing livestock population, rising government investments and initiatives to tackle the burden of animal diseases, and expanding pet care market across developing regions are anticipated to create growth avenues within the global veterinary vaccines market during the forthcoming years.
• The rapid surge in the animal healthcare market combined with the companion animal vaccines market is anticipated to generate lucrative prospects for the manufacturers of veterinary vaccines during the forecast period between 2022 and 2026.

Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-409

Competitive Landscape

Key players profiled in the global veterinary vaccines market are focusing on continuous investments in research and development activities for the introduction of effective vaccines. Besides this, leading veterinary vaccine manufacturers are adopting various market strategies such as joint ventures, collaborations, partnership agreements, sales agreements, and capacity expansion to expand their global footprint.

More Insights into the Veterinary Vaccines Market

The U.S. is anticipated to be a dominant market for veterinary vaccines attributing to the surging frequency of drug approvals, advances in veterinary science, rise in pet adoption rate, and the emergence of new veterinary vaccine market trends.

China is yet another country emerging as an opportunistic market for veterinary vaccines, combined by collaborative initiatives of governments and private firms in order to promote better animal healthcare with advanced veterinary medical devices.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-409

Key Companies Profiled

• Boehringer Ingelheim GmbH,
• Zoetis Inc.
• Elanco Animal Health,
• Merck & Co., Inc.
• Bayer AG
• Virbac Group
• Ceva Santé Animale
• Phibro Animal Health Corporation
• Others

Veterinary Vaccines Market Segmentation by Category

By Product:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

By Disease:

• Anaplasmosis
• Canine Parvovirus
• Foot & Mouth Disease
• New Castle Disease
• Distemper Disease
• Influenza
• Porcine Reproductive & Respiratory Syndrome (PRRS)
• Others

Use promo code >> FMITODAY to get flat 20% discount

By Distribution Channel:

• Veterinary Clinics
• Veterinary Hospitals
• Veterinary Research Institutes
• Retail Pharmacies

By Species:

• Companion Animals
  • Canine
  • Avian
  • Feline
• Livestock Animals
  • Aquatic
  • Bovine
  • Porcine
  • Ovine/Caprine
  • Poultry
• Equine

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

 

The market for Digital Breast Tomosynthesis (DBT) Equipment Market is anticipated to reach a valuation of US$ 2.3 billion in 2022 and to grow at a CAGR of 14.1% to US$ 8.4 billion by 2032. North America will hold a market share of roughly 51.3% of the global market in 2021, according to a recent study by Future Market Insights.

In this report, Future Market Insights (FMI) offers a 10-year forecast (2016–2026) of the digital breast tomosynthesis (DBT) equipment market. In terms of value, the digital breast tomosynthesis equipment market is expected to register a CAGR of 13.9% during the forecast period. This study demonstrates market dynamics and trends in major countries and regions, which are expected to influence the current environment and future status of the digital breast tomosynthesis equipment market over the forecast period.

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1241

Report Description

This report examines the global digital breast tomosynthesis equipment market for the period 2016-2026. The primary objective of the report is to offer insights into advancements in the digital breast tomosynthesis equipment market that are significantly helping transform the breast imaging market.

The digital breast tomosynthesis equipment market report begins by defining mammography and its types. It also lists the various mammography techniques. This is followed by an overview of the global digital breast tomosynthesis equipment market. The overview section includes FMI’s analysis of key trends, drivers, restraints and opportunities influencing growth of the global digital breast tomosynthesis equipment market. Impact analysis of key growth drivers and restraints based on the weighted average model has also been included in the report to better equip clients with country-specific trends and insights.

Rising incidence of breast cancer in developing countries with increasing life expectancy and increasing adoption of unhealthy lifestyles are primary factors driving growth of the digital breast tomosynthesis equipment. Hospitals and diagnostic centres are upgrading their existing digital mammography machines and installing new DBT equipment due to increasing evidences about effective combination of 2D and 3D mammography in cancer detection and reducing false positive call-backs. Combination of 2D and 3D mammography has become the new standard of care, since 3D mammography compliments conventional 2D mammography.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1241

The following section of the report highlights the global digital breast tomosynthesis equipment market by region. It provides a market outlook for 2016–2026 and sets the forecast within the context of the digital breast tomosynthesis equipment market. The study discusses the key regional trends contributing to growth of the digital breast tomosynthesis equipment market across the globe. It also analyses the degree to which global drivers are influencing this market in each regions.

The forecast presented here assesses the total revenue generated across the digital breast tomosynthesis equipment market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the digital breast tomosynthesis equipment market would develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis, i.e. by supply side, downstream industry demand and economic envelope.

It is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters such as Year-On-Year (Y-o-Y) growth rates, to understand the predictability of the global digital breast tomosynthesis equipment market and to identify the right opportunities the market presents. The global digital breast tomosynthesis equipment market segments in terms of product type, end user type and regional presence are analysed on the basis of their respective Basis Point (BPS) to understand the individual segment’s relative contribution to market growth. This detailed level of information is important for identification of various key trends in the respective market.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1241

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective.

In the final section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, to get a firm understanding of the key differentiators among competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the digital breast tomosynthesis equipment value chain and the potential players with regard to the same. This section also includes market strategies and SWOT analysis of the main players in the market.

Key Segments Covered

• By Product type
  • DBT Equipment
  • 3-D Upgradation
• By End User
  • Hospitals
  • Diagnostic centres

Key Regions Covered

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• MEA

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭@ https://www.futuremarketinsights.com/checkout/1241

Key Companies

• Hologic Inc.
• Siemens Healthineers
• Fujifilm Corporation
• GE Healthcare
• Internazionale Medico Scientifica S.r.l.
• Planmed OY

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The Europe Platelet Rich Plasma (PRP) Market is anticipated to reach US$ 42.75 million in 2022, and it is anticipated to reach US$ 84.10 million by 2032, with a CAGR of 7% through that time.

The Europe Platelet Rich Plasma (PRP) Market is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time.

By product type, PRP kits will continue to outsell instruments, accounting for over 75% revenue share of the market in 2016. Among the various platelet rich plasma kits, autologous kits will account for the highest demand on the basis of blood type, representing a market value worth US$ 24.2 Mn. P-PRF kits—valued at US$ 10 Mn in 2015—will witness the highest growth by end-product type, increasing at 8.6% in 2016.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-eu-1599

By application, adoption of PRP therapy will continue to remain highest in the treatment of knee and elbow injuries. While knee application segment revenues will grow by 7.2%, elbow application segment revenues are projected to grow by 6.3%. Use of PRP therapy in the treatment of ever-increasing incidences of osteoarthritis and tennis elbow will gain further traction in 2016 and beyond.

PRP revenues in the UK—the largest market in Europe—will grow by 7.3% in 2016, an increase of 0.20% from the 7.1% growth in 2015. High prevalence of sports-related incidents in the U.K., combined with high awareness about the benefits of PRP therapy among healthcare community and patients, will continue to fuel the growth of the market in the country.

France will maintain its position as the second largest market for PRP in Europe, growing by 6.5% in terms of revenues in 2016. France is home to subsidiaries and distributors of several PRP players, such as Biomet, Inc., DePuy Synthes, Inc., and Stryker Corporation and a range of highly innovative products are available in the market.

Johnson & Johnson Inc. and Stryker Corporation are the established players in the Europe PRP market. Johnson & Johnson’s PEAK Platelet Rich Plasma System and Stryker Corporation’s RegenKit THT Autologous Platelet-rich Plasma (A-PRP) will continue to witness sizeable sales in 2016. Arthrex – Arthrex Angel System from Arthrex Inc. and GPS® III Platelet Separation System by Zimmer Biomet Holdings Inc. will also account for substantial revenue share of the Europe PRP market.

Ask Us Your Questions About This Report@ https://www.futuremarketinsights.com/ask-question/rep-eu-1599

Long-term Outlook: The PRP market in Europe is expected to increase at a CAGR of 6.6% during the forecast period 2016-2024. The UK will continue to be at the forefront of overall demand, with France and Germany accounting for sizeable market share. While FMI maintains a positive outlook on the Europe PRP market, challenges, including lack of standardisation in preparation and dosage of autologous blood concentrate, and uncertainty about therapy efficacy can impede growth during the forecast period.

Drivers and Trends

The Europe PRP market was valued at US$ 35.3 Mn in 2015, and is projected to grow at a CAGR of 6.6% over the forecast period 2016-2024 owing to rising demand for PRP therapy in sport injuries.

Platelet-rich Plasma (PRP) therapy is a minimally invasive procedure and an alternative option to surgery. PRP therapy is a quick and highly effective treatment for reducing the pain and enhances tissue regeneration power with less recovery time along with higher success rates. PRP treatment is very cost effective compared to surgical procedures for orthopedic and sports injuries.

Some major factors driving the growth of PRP market are expanding PRP application in the sports medicine industry, technological advancements in PRP therapy, progressive demographic ageing of the older population etc. These factors are expected to fuel the growth of the market growth rate over the forecast period.

Get a Customized@ https://www.futuremarketinsights.com/customization-available/rep-eu-1599

Key Segments Covered

Product Type

• Instruments
• Kits
  • Kits BY Type
    • Pure Platelet-Rich Plasma (P-PRP)
    • Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
    • Leukocyte-Platelet-Rich Fibrin (L-PRF)
    • Pure Platelet-Rich Fibrin (P-PRF)
• Kits BY Origin
  • Autologous Platelet-Rich Plasma
  • Homologus Platelet-Rich Plasma
  • Allogeneic Platelet-Rich Plasma

By Application

• Knee
• Elbow
• Foot and Ankle
• Shoulder
• CMF
• Others

Use promo code >> FMITODAY to get flat 20% discount

Key Countries Covered

• Europe
• The U.K.
• France
• Germany
• Spain
• Italy
• Rest of Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

In 2022, it is expected that the Europe ViscoSupplementation Market would be worth more than US$ 4.5 billion. By 2032, the market for visco supplementation in Europe is anticipated to reach US$ 11 billion, growing at a CAGR of 9.37%.

Growing prevalence of osteoarthritis, strong healthcare infrastructure and well established reimbursements are soaring the demand for viscosupplementation market. The Europe viscosupplementation market has been segmented by product type, end user and region.

Rising prevalence of knee osteoarthritis is fuelling demand for effective treatment therapies. Hyaluronic acid-based intra-articular injections have proved to be one of the most preferred choices of treatment for symptomatic knee osteoarthritis. Hyaluronic acid-based intra-articular injections restore normal viscoelastic properties of altered synovial fluid in the knee joint, delivering effective therapeutic effect. The ultimate goal of viscosupplementation is to increase the concentration of hyaluronate in the joints so to restore the altered synovial fluid present in the joints.

To remain ‘ahead’ of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-EU-1383

Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”. In terms of revenue, the Europe viscosupplementation market is projected to register a healthy CAGR of 5.1% during 2016-2026.

FMI’s report has segmented the market on the basis of product type, end user and region.

Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits. The segment is expected to register the highest CAGR of 6.7% during the forecast period.

Five injection viscosupplementation product type segment is expected to witness a decline in market share in terms of revenue from 29.0% in 2015 to 23.3% in 2026. This decline is attributed to more incidence of side effects and repeated patient visit requirements associated with five injection viscosupplementation. Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals end-use segment is expected to witness significant demand for viscosupplementation, registering a CAGR of 4.3% over the forecast period. Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1383

Europe Viscosupplementation Market Trends

Key trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market. For example, the product pipeline of major players in the viscosupplementation market involves combining corticosteroid injections, which help in relieving pain associated with osteoarthritis, with long-lasting effects of hyaluronic acid, which lasts for nearly six months. Further, regional competition within EU countries, especially in five injection cycle, is leading to entry of new market players. Europe is a mature market in terms of generic products and it is therefore relatively easier to obtain CE mark in Europe than it is to obtain the U.S. FDA approval.

Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015, attributed to factors such as the presence of key regional players, strong distribution network and better healthcare infrastructure in the region.

Key Players in Europe Viscosupplementation Market

• Anika Therapeutics Inc.
• Sanofi S.A.
• Zimmer Biomet Holdings
• Meda AB
• Ferring B.V
• Fidia Pharmaceutici S.p.A
• Bioventus LLC.

We have discussed individual strategies followed by these companies in terms of enhancing product designs, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways that could help players already present in the market and new players planning to enter the market in the long run.

Market Dynamics

Growth of the Europe viscosupplementation market is mainly driven by rising obesity rates and growing patient awareness about effective treatment therapies for knee osteoarthritis, coupled with macroeconomic factors such as high unmet patient needs and strengthening of distribution network by key players in the viscosupplementation market.  Other prominent growth drivers include rapidly growing medical technology industry and cost-effectiveness of the treatment. However, economic issues in some Eastern European countries and reimbursement cutbacks are expected to hamper overall growth of the viscosupplementation market in Europe over the forecast period.

Viscosupplementation devices are classified under Class III category in Europe and are considered high-risk devices. They require premarket approval from notified bodies, including private organisations recognised by the European Free Trade Association (EFTA).

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1383

Key Segments

• Product Type
  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation
• End User
  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedic Clinics

 Key Regions/Countries

• Western Europe
  • K.
  • France
  • Germany
  • Spain
  • Italy
  • Nordics
  • Rest of Western Europe

Eastern Europe

• Russia
• Rest of Eastern Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

By 2033, it’s expected that the Light Therapy Market industry’s net value will have grown from US$ 1.0 billion to US$ 1.8 billion. Because of major depressive disorders, seasonal affective disorder (SAD), and numerous skin-related conditions, there is a growing demand for light therapy, and it is anticipated that this demand will grow at a CAGR of 5.7% from 2023 to 2033. The global burden of melancholy is projected to have doubled by 2030. Therefore, well-known providers of light therapy have a lot of room for development.

During the forecast period, the market for light therapy is anticipated to expand significantly. By the first half of this decade, the target market will probably be worth more than US$ 1 Bn. Due to the rising demand for light therapy in the healthcare industry, there are numerous possibilities for market growth. Over the coming years, rising rates of depression and insomnia will further fuel the market for light treatment.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1160

In the past few years, there’s been a surge in the incidences of individual depression and insomnia.  In addition to depression and insomnia, disrupted sleep cycles have contributed to the popularity of light therapy. These conditions have induced a wide platform for improved sales of progressive treatment equipment that employs high-quality ultraviolet light to treat these disorders.

A World Bank report states that, if left untreated, mental ailments such as depression are likely to cause economic losses of US$ 2.5-8.5 trillion globally, a figure that most expect to double by 2030. Thus, the market of light therapy is anticipated to undergo tremendous growth in the near future. In addition to mental illness, light therapy products are also known to relieve seasonal affective disorders (SADs) in particular, by improving serotonin levels. Light therapy also helps treat and manage various skin conditions. As a result, many key market participants offer phototherapy for skin conditions.

With rising insomnia cases, the demand for light therapy is also increasing. Light therapy rectifies the patient’s circadian rhythm which, in turn, assists in improving sleep outcomes. Many leading market participants offer light therapy that addresses insomnia and helps insomniacs and night shift workers. All of these considerations, along with many others, aid the growth of the light therapy market during the forecast period.

Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1160

“Rising adoption of the target product to treat and manage dermatological conditions will likely stimulate the global growth of the light therapy market over the forecast period,” says an FMI analyst.  

Key Takeaways:

• The risk of skin damage due to UV-light exposure may stymie market growth.
• Increasing incidences of seasonal affective disorder (SAD) promote growth in the U.S light therapy market.
• Photodynamic therapy fuels the light therapy market in Germany.
• By product, handheld devices will gain popularity over the assessment period.
• On the basis of light type, the red light segment will generate the most demand.

Competitive Landscape 

Koninklijke Philips N.V., Verilux Inc., Northern Light Technology, Sphere Gadget Technologies, Zepter International, PhotoMedex Inc., Luminette, Klarstein, Lumie, and Aura Daylight among others are some of the major players in the light therapy market profiled in the full version of the report.

Leading market players are keen on new product releases and expanding their capacities. These businesses employ strategies like product innovations, mergers, acquisitions, and partnerships to gain a competitive edge.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1160

More Insights into Light Therapy Market Report

In its latest report, FMI offers an unbiased analysis of the global light therapy market, providing historical data from 2016 to 2020 and forecast statistics for 2021 to 2031. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (light box, floor and desk lamps, light visor, dawn stimulator, light therapy bulbs), light type (white light, blue light, red light), end user (dermatology clinics, homecare settings, others (workplace, salons)), and region.

According to the latest FMI reports, based on segmentation, the red light segment will contribute substantially to the overall market growth. This segment is gaining traction due to its ability to strengthen mitochondria by generating a biochemical effect within cells. In terms of end-user, dermatology clinics will dominate the global market space during the forecast period.

Based on region, the light therapy market in the United States will demonstrate considerable growth during 2021-2031. As there is an increasing prevalence of seasonal affective disorder (SAD) in this region, the demand for light therapy is also high. Again, there’s been a notable surge in illnesses like depression and insomnia which further amplify the demand for light therapy in the U.S. Apart from the United States, the U.K. and Germany will present impressive growth in the light therapy market during the forecast period.

Use promo code >> FMITODAY to get flat 20% discount

Light Therapy Market Segmentation by Category

By Product:

• Light Box
• Floor and Desk Lamps
• Light Visor
• Dawn Simulator
• Light Therapy Bulbs

By Light Type:

• White Light
• Blue Light
• Red Light

By End User:

• Dermatology Clinics
• Homecare Settings
• Others (Workplace, Salons)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The Hospital Capacity Management Solutions Market is anticipated to grow on average at a CAGR of 5.1% during the forecast timeframe. As a result, the industry is expected to generate US$ 1.9 billion in sales by 2033, with a share of US$ 1.1 billion in 2023. According to FMI, a market research company that has earned ESOMAR certification, the global market for hospital capacity management solutions will grow by 4.9% year over year in 2022 to hit US$ 1.08 billion.

Large patient care facilities are using hospital capacity management systems to ensure a smooth workflow in terms of downtime and expense. During the forecast period, this element is anticipated to push the market for hospital capacity management solutions.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1013

Key Takeaways of Hospital Capacity Management Solutions Market Study

• RTLS (Real time locating system) accounted for around 34% of hospital capacity management solutions market in 2021 and is expected to continue with being top-seeded in the forecast period
• Cloud-based hospital capacity management solution contributed for around 3/5th of market value share in 2021
• Cumulatively, North America and Europe contributed for more than 70% of the total share of the hospital capacity management solutions market in 2021
• Countries such as Brazil, China, South Africa, and India are expected to are emerging as lucrative markets, but pale in comparison to US and Europe

Expansive Prominence in the hospital capacity management solutions market

Taking the expansive way of growth helps in strengthening the solutions’ and software’s portfolio; as e-Health has picked up pace looking at the accuracy and need for data management.

Ask Us Your Questions About This Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-1013

• STANLEY Healthcare, in May 2022, announced the assimilation of AeroScout Real-Time Location System (RTLS) with certification from Cisco DNA Spaces. The objective of this move is to table economic solution across the healthcare industry
• Allscripts has its “2bPrecise” platform that takes in clinical information from the EHR preferred by client along with genomic/genetic data from the molecular labs, thereby giving a comprehendible patient record. This gives precise diagnoses at a faster rate.
• TeleTracking Technologies have their Capacity Management Suite with PreAdmitTracking with electronic bedboard to enable patient access as well as placement

“Precise, real-time navigation with the patient will boost the hospital capacity management solutions market.” says the FMI Analyst.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1013

Scope of the Report

Major Contributors of the Hospital Capacity Management Solutions Market are:

• Cerner Corporation
• Epic Systems Corporation
• TeleTracking Technologies, Inc.
• Sonitor Technologies, Inc.
• STANLEY Healthcare
• Allscripts
• McKesson Corporation
• Arcomed AG
• Koninklijke Philips N.V.
• JVS Group
• Infosys Limited
• Neusoft Corporation
• INFINITT Healthcare Co. Ltd
• AWAREPOINT CORPORATION
• Care Logistics LLC

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global hospital capacity management solutions market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭@ https://www.futuremarketinsights.com/checkout/1013

The study provide compelling insights on hospital capacity management solutions market on basis of product type (workflow management solution, asset management solution, bed management solution, quality patient care solution, real time locating system (RTLS), and event driven solutions { online registration solution, attendance management tools, event driven patient tracking, others}), application (standalone solutions, integrated solutions), delivery mode (on premise, cloud-based) across seven major regions

Key Segments

By Product:

• Workflow Management Solution
• Asset Management Solution
• Bed Management Solution
• Quality Patient Care Solution
• Real Time Locating System (RTLS)
• Event Driven Solutions
  • Online Registration Solution
  • Attendance Management Tools
  • Event Driven Patient Tracking
  • Others

By Application:

• Standalone Solutions
• Integrated Solutions

By Delivery Mode:

• On Premise
• Cloud-Based

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

It is anticipated that the worldwide Ophthalmic Diagnostic Equipment Market will offer an opulent growth opportunity, rising at a CAGR of 6.7% from a valuation of US$ 3.0 billion in 2022 to US$ 5.1 billion by 2030.

The market for ophthalmic devices, which was projected to be worth approximately USD 55.0 billion in 2021, received more than 5.5% of its market share from the worldwide ophthalmic diagnostic equipment market.

According to an FMI assessment, the market for ophthalmic diagnostic tools is predicted to grow by 44 basis points (BPS) between H1-2021 and H1-2022(O). However, a comparison of the projected and outlook growth rates for the H1-2022 timeframe revealed a 10 BPS decrease in growth rate.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-771

Key Takeaways

• The number of individuals suffering from serious eye diseases is rising at a global level due to which loss of vision is becoming a major public health problem. As the population has increased, the prevalence of eye diseases has also surged due to the rise in chronic diseases such as diabetes and hypertension have become more common leading to issues like glaucoma or vision impairment.
• There is an increase in the number of people who are blind or have impaired vision in the upcoming years. With the rising frequency of eye disorders and the resulting increase in disability-adjusted life years (DALYs), demand for precise disease treatment is likely to increase in the future years.
• Increasing technological advancements in analytical methods help in offering improved quantification and characterization with high-resolution cross-sectional 3D images of the target tissue that is difficult to view using a conventional microscope. Owing to such high-tech equipment, the surge in the ophthalmic diagnostic equipment market can be witnessed.
• The emergence of advancement in technologies have provided improved quantification and Intraoperative optical coherence tomography (OCT) aids accurate decision-making during eye surgery by providing real-time imaging with simultaneous feedback features.
• An increase in the demand for optical coherence topography devices has led to a rise in competition among players. As a strategy to reach the larger masses, various players/manufacturers have lowered the costs of their devices, which in turn has led to the adoption of these devices by doctors in emerging economies along with developed countries. This factor is anticipated to drive demand for these devices in emerging economies in near future.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-771

Competitive Landscape

TOPCON CORPORATION, ZEISS International, Ellex, Quantel Medical, NIDEK CO., LTD., HAAG-STREIT GROUP, Halma plc, Coburn Technologies Inc., Kowa Company Ltd. are some of the key companies profiled in the full version of the report.

Major competitors in the ophthalmic diagnostic equipment market are concentrating their efforts on expanding their worldwide and regional footprints through strategic acquisitions and mergers, as well as operational growth.

Companies in the ophthalmic diagnostic equipment market are following new product innovations and launches, regulatory approvals, and acquisitions as the key strategies. Key players are focusing on the development of advanced and cost-effective products and establishing distribution agreements to increase geographic reach, especially in the Asia Pacific region. Moreover, companies are targeting Asia region by establishing manufacturing units in order to reduce manufacturing costs.

More Insights into Ophthalmic Diagnostic Equipment Market

The United States is anticipated to rule the ophthalmic diagnostic equipment market accounting for over 89.2% of the North American region. Owing to the increased prevalence of refractive error disorders, the increased number of eye condition awareness programs, and the increased use of superior diagnostic technology are all contributing to this increase.

Germany accounted for approximately 28.6% of the Western Europe market in 2021. According to Eurostat one of the most common surgical procedures in Europe is cataract surgery. The rising number of cataract operations has had a significant influence on the ophthalmic industry, resulting in increased demand for cataract surgery equipment and medications.

China accounted for about 40.4% of the APEJ region in 2021. Factors such as the increasing number of people belonging to the older population that suffer primarily from poor eyesight and other eye-related diseases such as glaucoma and cataract contributed to market growth in this region.

India accounted for a 13.1% market share of APEJ in 2021 and is expected to show a similar trend in the coming years also. In India, ophthalmology-related disorders are on the rise. In India, almost 5 million cataract procedures are conducted every year. The bulk of these operations includes the implantation of intraocular lenses.

Ask Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-771

Ophthalmic Diagnostic Equipment Market by Category

By Product:

• Fundus Cameras
• Retinal Ultrasound Imaging Systems
• Refractors
• Slit Lamps
• Perimeters
• Ophthalmoscopes
• Tonometer
• Optical Coherence Tomography (OCT)
• Corneal Topography Systems

By End user:

• Hospitals
• Clinics
• Ambulatory Surgical Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 09-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

In 2022, the Hyperbaric Oxygen Therapy Devices Market is anticipated to be worth US$3.21 billion. The overall demand for hyperbaric oxygen therapy devices is anticipated to increase at a CAGR of 7.1% between 2022 and 2032, reaching approximately US$ 6.37 billion by 2032 due to the growing use of hyperbaric oxygen therapy in wound healing and the increasing number of athletes driving up demand for HBOT.

The use of the hyperbaric oxygen therapy (HBOT) method improves leukocyte performance, particularly at the site of a wound, and reduces the toxicity of cyanide and carbon monoxide (CO). One of the major factors anticipated to propel the market during the forecast period is the technology’s increasing acceptance on a worldwide scale.

Get a Sample PDF Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1099

Rising number of patients with diabetes around the globe is the prime factor for the increase in demand of hyperbaric oxygen therapy devices. Thus, the market is to witness an upward trend with the passing years. Additionally, the market is set to gain because of the increasing medical tourism. The support and investment by the government of the developing reasons in the healthcare sector too cannot be ignored for the rise in demand. Plus, nowadays, patients with brain injuries and cancer are also being treated using this technology.

The regulatory approval for a number of indications such as pulmonary embolism, severe anemia, decompression sickness, burns and brain abscesses to name a few out of the thirteen approved indications, is one of the major factors that is expected to escalate the growth of the hyperbaric oxygen therapy device market over the analysis period. Moreover, the increasing adoption of hyperbaric oxygen therapy devices for lung disease treatment and prevention of reperfusion injury is one of the major factors that is expected to propel the market growth during the forecast period.

The North America hyperbaric oxygen therapy devices market is expected to accumulate a market share of 34.0% in 2022. North America is anticipated to be the largest market for Hyperbaric Oxygen Therapy Devices, owing to reasons such as the growing population and the increasing preference for wound healing treatments.

Talk to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1099

Key Takeaways from the Market Study

• Global Hyperbaric Oxygen Therapy Devices Market was valued at US$ 3.21 Billion by 2022-end
• From 2017 to 2021, Hyperbaric Oxygen Therapy Devices demand expanded at a CAGR of 4.2%
• By product, monoplace hyperbaric oxygen therapy devices to acquire a revenue share of 54%.
• By Application, the Wound Healing segment dominates the Hyperbaric Oxygen Therapy Devices Market with a CAGR of 31%.

“The ability of the hyperbaric oxygen therapy procedure to effectively treat carbon monoxide poisoning, is one of the major factors that is anticipated to accelerate the growth of the hyperbaric oxygen therapy devices market in the near future,” remarks an FMI analyst.

Competitive Landscape

Players in the global Hyperbaric Oxygen Therapy Devices Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

• In May 2021, CūtisCare, a leading provider of multi-place hyperbaric services for trauma centers and acute care hospitals, announced the official launch of hyperbaric aware website and national campaign. CūtisCare aims to increase awareness about hyperbaric oxygen therapy to effectively deal with various chronic conditions.
• In November 2019, AHA Hyperbarics introduced the AHA Flex V2, a new model of innovative high-pressure medical hyperbaric chambers that are specifically built to meet the growing need for HBOT safety and efficacy.
• In July 2019, Unique Group, the world’s prominent advanced subsea, offshore, and life support solution providers, launched its next generation multiplace hyperbaric oxygen treatment chamber, ‘Uni-Heal 2200 hyperbaric oxygen treatment facility’.
• In February 2019, new medical research conducted at the LSU Health New Orleans School of Medicine indicates that the procedure can be beneficial for the patients of Alzheimer’s, when conducted with other therapies or by itself.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1099

Key companies profiled : Cardinal Health, Mölnlycke Health Care, Acelity L.P. Inc. (3M), Lohmann & Rauscher GmbH & Co. KG, Smith & Nephew, ConvaTec Inc., DeRoyal Industries, Inc., HARTMANN, Medela LLC, Haromed Bvba (Belgium), Carilex Medical GmbH. Genadyne Biotechnologies, Inc., Cork Medical, LLC, Alleva Medical Ltd. (Devon Medical Products, and Argentum Medical, LLC

Key Segments Covered in the Hyperbaric Oxygen Therapy Devices Industry Analysis

Hyperbaric Oxygen Therapy Devices Market by Type of Products:

• Mono-place HBOT Devices
• Multi-place HBOT Devices
• Topical HBOT Devices

Hyperbaric Oxygen Therapy Devices Market by Application:

• Wound Healing
• Decompression Sickness
• Infections
• Gas Embolism
• Others

Buy this Report Now @ https://www.futuremarketinsights.com/checkout/1099

Hyperbaric Oxygen Therapy Devices Market by Region:

• North America
• Europe
• Asia Pacific
• Rest of the World (ROW)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to the most recent research report from ESOMAR-certified Future Market Insights (FMI), the Automated Breast Ultrasound Systems Market has been greatly fueled by the increasing prevalence of breast cancer around the world and the expansion of government programmes to promote breast cancer awareness. According to the study, over the next ten years, the market for automated breast ultrasound systems would expand at a CAGR of about 10%.

Leading manufacturers are working hard to create an ultrasound breast imaging device that is quicker, more accurate, and less invasive. The National Library of Medicine reported that the combination of automated breast ultrasonography and mammography raised the system’s sensitivity to 99.1%.

Get a PDF Sample with Latest Market Insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-606

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

• Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.
• The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.
• Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany
• Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.
• India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.
• Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

Ask from Market Research Expert @
https://www.futuremarketinsights.com/ask-question/rep-gb-606

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

More Insights on the Global Automated Breast Ultrasound Systems Market

In its latest report, FMI offers an unbiased analysis of the global automated breast ultrasound system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of end user (hospitals, diagnostic imaging laboratories), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan,  and Middle East & Africa)

Last few days to get reports at discounted prices, offer expires soon!
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-606

Key Segments Covered

By End User

• Hospitals
• Diagnostic Imaging Laboratories

•  America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Western Europe
  • EU-5
  • BENELUX (Belgium, Netherlands, Luxembourg)
  • NORDIC (Denmark, Finland, Iceland, Norway, Sweden)
  • Rest of Europe
• Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
• Japan
• APEJ (Asia Pacific excluding Japan)
  • China
  • India
  • ASEAN Countries
  • Australia & New Zealand
  • Rest of APEJ
• MEA
  • GCC Countries
  • South Africa
  • Israel
  • Turkey
  • Iran
  • Rest of Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to the most recent study report from ESOMAR-certified Future Market Insights (FMI), the Automated CPR Devices Market has been growing significantly as sudden cardiac arrest rates increase globally. According to the study, the worldwide market for automated CPR devices is anticipated to expand at a CAGR of roughly 13% from 2021 to 2031.

The market is expected to expand considerably over the next ten years as more coronary and intensive care units turn to automated CPR devices due to their high efficacy. Significant advancements have been made with 3D automated CPR devices, particularly when standard CPR equipment is used in conjunction with torso restraints to provide vertical compression and high-quality resuscitation.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-720

Automated CPR devices experienced a surge in demand during the Covid-19 pandemic. COVID-19 infected heart patients were more susceptible to cardiac arrest in comparison with non infected patients. With rapid mutation of virus, the patients were facing higher risk of cardiac arrest.

 “Rising consumer awareness regarding benefits of CPR devices and increasing adoption in EMT services will amplify sales of automated CPR devices during the forecast period,” says the FMI analyst.

Key Takeaways from FMI’s Automated CPR Devices Market Study

• Presence of modern healthcare infrastructure and high per capita income will bolster demand across the U.S.
• The U.K is expected to offer growth opportunities as governments and private organizations are working towards spreading awareness regarding dangers of cardiovascular diseases.
• Rising prevalence of obesity and high blood pressure which are precursor to cardiac arrest will increase automated CPR devices adoption across France.
• China will offer lucrative opportunities owing to increasing alcohol and tobacco consumption and developing healthcare infrastructure.
• India is expected to exhibit impressive market growth owing to increase in geriatric population and growing incidence of sudden cardiac arrest in the country.

Competitive Landscape:

Automated CPR market is highly consolidated owing to presence of regional and global market players. Key market players in automated CPR devices market are focusing towards employing inorganic market strategies to expand their global foothold.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-720

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels. They are also emphasizing towards faster product approvals, product development and patenting. New market entrants are focusing on new product launches to establish their market presence.

For instance, Michigan Instruments launched hand-free automatic CPR device which is light weight, portable and helps in smooth transition from manual CPR to automated compressions.

ZOLL Medical Corporation introduced a new automated CPR devices system “Autopulse” which assists EMS personnel in providing high quality chest compressions in cramped spaces and steep down stairwells.

Prominent players operating in the automated CPR devices market are SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., Brunswick Biomedical Technologies, Zhuhai Kindway Medical Science & Technology Co. Ltd, CPR Medical Devices Inc., and Medtronic Inc.

In its latest report, FMI offers an unbiased analysis of the global automated CPR devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of power source (pneumatically driven CPR devices, battery driven CPR devices, and mechanically actuated and battery driven CPR device), device type (piston devices, load distribution devices, and 3D compression devices) and end user for (Ems, hospitals, ambulances, coronary & intensive care units, cardiac catheterization labs, air med-evac units, and EMT rescue units) across North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

For more Report Customization, connect with us at@ https://www.futuremarketinsights.com/customization-available/rep-gb-720

Key Segments Covered:

By Power Source:

• Pneumatically Driven CPR Devices
• Battery Driven CPR Devices
• Mechanically Actuated And Battery Driven CPR Device

By Device Type:

• Piston Devices
• Load Distribution Devices
• 3D Compression Devices

Use promo code >> FMITODAY to get flat 20% discount

By End User:

• EMS
• Hospitals
• Ambulances
• Coronary & Intensive Care Units
• Cardiac Catheterization Labs
• Air Med-Evac Units
• EMT Rescue Units
• Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs